...
首页> 外文期刊>The lancet oncology >Cemiplimab in locally advanced cutaneous squamous cell carcinoma: results from an open-label, phase 2, single-arm trial
【24h】

Cemiplimab in locally advanced cutaneous squamous cell carcinoma: results from an open-label, phase 2, single-arm trial

机译:Cemimlimab在局部先进的皮肤鳞状细胞癌:开放标签,第2阶段,单臂试验结果

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Background Cemiplimab has shown substantial antitumour activity in patients with metastatic cutaneous squamous cell carcinoma. Patients with locally advanced cutaneous squamous cell carcinoma have poor prognosis with conventional systemic therapy. We present a primary analysis of the safety and antitumour activity of cemiplimab in patients with locally advanced cutaneous squamous cell carcinoma.
机译:背景技术Cemiplimab在转移皮肤鳞状细胞癌患者中表现出实质的抗肿瘤活性。 临床皮肤鳞状细胞癌的患者对常规全身治疗预后差。 我们对局部先进的皮肤鳞状细胞癌患者CeMimimab的安全性和抗肿瘤活性进行了初步分析。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号